Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:E42 (4 October), doi:10.1136/bmjusa.01060005 (published 5 September 2002)
This article originally appeared in BMJ USA
EditorI use the National Cancer Institute's Breast Cancer Risk Assessment Tool for risk stratification. This is the software tool used in the Breast Cancer Prevention Trial with tamoxifen. It uses the "Gail model," which includes known risk factors such as age, personal history of breast abnormalities, age at menarche, age at first live birth, family history, breast biopsies, and race. I have the software both on a PC and on my Palm PDA (Personal Digital Assistant).* A PDA Gail model program is available at http://pbrain.hypermart.net/medrules.html.
I give the patient her five-year risk of breast cancer, and I offer her mammography if she wishes. Mammograms after the age of 50 offer a mortality reduction of about 25%; due to the greater likelihood of rapid progression in younger women, they should have mammograms yearly instead of every two years.
Perhaps the time has come to offer risk stratification at the bedside, based on multifactorial risk analysis. This is now possible. I tend to use the Palm version more often than the PC version, because of its easy accessibility.
Michelle Greiver, lecturer
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada mgreiver{at}home.com
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.